The company's management team aligns operations and investments with key strategic pillars through continuous focus on objectives such as improving the ability to serve customers and enhance customer experiences through the digitalization of internal processes and go-to-market approaches. We continue to invest in research and development that will result in category innovation and a robust product pipeline, leveraging our global scale to expand our reach in providing access to affordable medical technologies around the world, including emerging markets. Our ability to sustain long-term growth will depend on factors including our ability to expand our core business, develop innovative new products, and continue to improve operating efficiency and organizational effectiveness. We have deployed our capabilities, expertise, and scale to address critical health needs related to COVID-19, including the development of rapid testing solutions and partnerships with governments for vaccination campaigns. The ongoing COVID-19 pandemic has led to significant declines in healthcare utilization and demand for our products, impacting our operational performance and necessitating the implementation of business continuity plans to mitigate disruptions. We have enacted cost containment measures to address the unfavorable impact of the pandemic on our results of operations, including temporary reductions in executive compensation and work reductions for certain manufacturing teams. Our financial position remains strong, with cash flows from operating activities totaling $3.539 billion in 2020, and we continue to evaluate our performance on both reported and foreign currency-neutral bases to improve investor understanding. The companyâ€™s strategic objectives include simplifying operations by reducing complexity across our manufacturing network and rationalizing our product portfolio, which enhances our quality and risk management systems. Our investment in technology management and operational flexibility is crucial for maintaining competitive advantage and responding to market dynamics. We are committed to fostering a purpose-driven culture that focuses on positive impacts for all stakeholders, which includes enhancing our information management capabilities to provide timely and reliable data to users. The integration of our operations and the enhancement of our IT capabilities are essential for achieving our organizational goals and improving overall performance metrics. As we navigate the challenges posed by the pandemic and market pressures, our focus on digital transformation and strategic resource allocation will be pivotal in driving future growth and maintaining our position as a competitive force in the medical technology industry.